Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tablet workouts cut fall risk for dementia patients in new study

NCT ID NCT06149702

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special tablet exercise program called KOKU-LITE, designed for people with dementia to help prevent falls and improve well-being. Sixty people with dementia and their carers took part to see if the program was easy to use and helpful. The goal was to see if this digital tool could boost confidence, independence, and quality of life while reducing hospital visits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jun 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participant inclusion criteria: People living with dementia (PLwD) and carers of PLwD Participants will be selected purposively to derive a maximum variation sample including age, gender, diverse representation from different backgrounds and different levels of Dementia, early cognitive decline and different stages of disease progression thus, increase the external generalisability of the results. * PLwD and carers of PLwD aged ≥55 yrs * willing and able to give informed consent (assessed by the trained researchers and/or health and social care professionals (HSCPs)). * who lack capacity to consent themselves but can be supported by a carer or an advocate. * Carers of PLwD who lack capacity to consent themselves. * able to speak English. * able to see the tablet/iPad-based app and read instructions with or without glasses. * able to use tablet/iPad safely, as assessed by the trained research staff and/or HSCPs. * able to move indoors without help, and with or without a walking aid. Professionals • HSCPs caring for PLwD Exclusion Criteria: PLwD * Participants with: * Acute/chronic or uncontrolled medical condition (e.g. severe congestive cardiac failure, uncontrolled hypertension, acute systemic illness, neurological problems, poorly controlled diabetes). * recent fracture or surgery (within 6 months) * orthopaedic surgery (such as hip/knee surgery) in the past six months or on a waiting list to have the surgery. * heart problems such as myocardial infarction or stroke in the past six months * conditions requiring a specialist/exercise programme (e.g., uncontrolled epilepsy, or uses a wheelchair to mobilise indoors). * severe hearing/visual impairment. * any other medical condition likely to compromise the ability to use/access the app. * Participants currently in hospital or care home, * Participants who have limited understanding or ability to speak English, and . * Persons with Dementia who do not have a carer who can provide assent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Manchester

    Manchester, M13 9PL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.